<DOC>
	<DOCNO>NCT00249951</DOCNO>
	<brief_summary>Preterm infant risk develop nephrocalcinosis . Incidence number vary accord birth weight gestation age . Very low birth weight infant high risk index , ~ 7-10 % preterm infant develop nephrocalcinosis patient population . We , researcher University Cologne , others find significantly decrease urinary citrate excretion ( hypocitraturia ) one main risk factor . Hence , hypothesize , prophylactic treatment oral alkaline citrate solution ( Shol 's solution ) would help 1 ) increase urinary citrate excretion 2 ) help decrease incidence nephrocalcinosis .</brief_summary>
	<brief_title>Alkaline Citrate Treatment Lower Risk Nephrocalcinosis Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Nephrocalcinosis</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Preterm infant &lt; 32 week gestation age &lt; 1500 g birth weight Cardial , renal gastrointestinal malformation Chronic renal failure Therapy vitamin B6 High dose treatment furosemide dexamethasone Addison 's disease Severe metabolic alkalosis Worse clinical condition preterm infant , make oral feed impossible Participation study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>8 Weeks</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>nephrocalcinosis</keyword>
	<keyword>premature infant</keyword>
	<keyword>hypocitraturia</keyword>
	<keyword>alcaline citrate therapy</keyword>
	<keyword>Nephrocalcinosis premature infant</keyword>
</DOC>